BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26

• 

  Drug Development

  Regeneron, Sanofi’s Dual-Action Biotech Asthma Drug Performs Well In Key Test

  November 11, 2014

   · 

  2 min read
• BioMidwest

  Device Changes Your Mood With A Zap To The Head, Arizona State University Reveals

  November 11, 2014

   · 

  1 min read
• 

  Drug Development

  Confident Merck & Co. Expects No Writedowns For Zetia, Vytorin Cholesterol Drugs

  November 11, 2014

   · 

  2 min read
• Can’t Clap To The Beat? You Might Be Beat-Deaf, McGill University Study

  November 11, 2014

   · 

  3 min read
• Biotech Bay

  10 Medical Device Finalists Vying For Medtech Innovator Title

  November 11, 2014

   · 

  1 min read
• 

  Business

  AVEO Oncology, Ophthotech Corporation Forge Research, License Deal Worth $105 Million+

  November 11, 2014

   · 

  1 min read
• A New Nanomachine Shows Potential For Light-Selective Gene Therapy, University of Tokyo Study

  November 11, 2014

   · 

  1 min read
• 

  Business

  Drugmakers Like Johnson & Johnson, Emergent BioSolutions, And Mapp Biopharmaceutical Stand To Gain Ebola Contracts Worth $2 Billion

  November 11, 2014

   · 

  1 min read
• Biotech Bay

  What Exactly Is Google Inc.'s “Cancer Nanodetector”?

  November 11, 2014

   · 

  1 min read
• 

  Pharm Country

  Regeneron, Sanofi Asthma Drug A Potential Blockbuster For Allergies, Says Analyst

  November 11, 2014

   · 

  1 min read